CN1587270A - 含有血管紧张素转化酶抑制剂和b族维生素的药物组合物 - Google Patents
含有血管紧张素转化酶抑制剂和b族维生素的药物组合物 Download PDFInfo
- Publication number
- CN1587270A CN1587270A CN 200410071056 CN200410071056A CN1587270A CN 1587270 A CN1587270 A CN 1587270A CN 200410071056 CN200410071056 CN 200410071056 CN 200410071056 A CN200410071056 A CN 200410071056A CN 1587270 A CN1587270 A CN 1587270A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- group
- acei
- content
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (21)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410071056 CN1269529C (zh) | 2004-07-28 | 2004-07-28 | 含有血管紧张素转化酶抑制剂和b族维生素的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200410071056 CN1269529C (zh) | 2004-07-28 | 2004-07-28 | 含有血管紧张素转化酶抑制剂和b族维生素的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1587270A true CN1587270A (zh) | 2005-03-02 |
CN1269529C CN1269529C (zh) | 2006-08-16 |
Family
ID=34604567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200410071056 Expired - Lifetime CN1269529C (zh) | 2004-07-28 | 2004-07-28 | 含有血管紧张素转化酶抑制剂和b族维生素的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1269529C (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009046631A1 (fr) * | 2007-09-28 | 2009-04-16 | Beijing Huaanfo Biomedical Research Center, Inc | Composition pharmaceutique contenant un inhibiteur d'enzyme de conversion de l'angiotensine et des vitamines b, et son utilisation |
CN101869710A (zh) * | 2009-04-24 | 2010-10-27 | 北京奥萨医药研究中心有限公司 | 降压药物组合物 |
CN101590084B (zh) * | 2008-05-29 | 2012-12-05 | 北京奥萨医药研究中心有限公司 | 含有血管紧张素转化酶抑制剂、b族维生素和银杏叶提取物的药物组合物 |
CN103222960A (zh) * | 2013-05-15 | 2013-07-31 | 中国药科大学 | 一种马来酸依那普利口服定时释放微丸及其制备方法 |
CN103386130A (zh) * | 2013-06-27 | 2013-11-13 | 深圳奥萨医药有限公司 | Ace抑制剂/噻嗪类利尿剂/5-甲基四氢叶酸药物组合物及用途 |
CN106310218A (zh) * | 2015-11-27 | 2017-01-11 | 深圳奥萨制药有限公司 | 含依那普利和叶酸的片剂组合物及其制备方法 |
CN106963938A (zh) * | 2016-09-30 | 2017-07-21 | 南京优科制药有限公司 | 一种马来酸依那普利叶酸的药物组合物及其制备方法 |
CN107007838A (zh) * | 2016-09-30 | 2017-08-04 | 南京优科制药有限公司 | 一种含有马来酸依那普利、叶酸和酸稳定剂的药物组合物 |
-
2004
- 2004-07-28 CN CN 200410071056 patent/CN1269529C/zh not_active Expired - Lifetime
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009046631A1 (fr) * | 2007-09-28 | 2009-04-16 | Beijing Huaanfo Biomedical Research Center, Inc | Composition pharmaceutique contenant un inhibiteur d'enzyme de conversion de l'angiotensine et des vitamines b, et son utilisation |
CN101590084B (zh) * | 2008-05-29 | 2012-12-05 | 北京奥萨医药研究中心有限公司 | 含有血管紧张素转化酶抑制剂、b族维生素和银杏叶提取物的药物组合物 |
CN101869710A (zh) * | 2009-04-24 | 2010-10-27 | 北京奥萨医药研究中心有限公司 | 降压药物组合物 |
CN103222960A (zh) * | 2013-05-15 | 2013-07-31 | 中国药科大学 | 一种马来酸依那普利口服定时释放微丸及其制备方法 |
CN103222960B (zh) * | 2013-05-15 | 2016-06-15 | 中国药科大学 | 一种马来酸依那普利口服定时释放微丸及其制备方法 |
CN103386130A (zh) * | 2013-06-27 | 2013-11-13 | 深圳奥萨医药有限公司 | Ace抑制剂/噻嗪类利尿剂/5-甲基四氢叶酸药物组合物及用途 |
CN106310218A (zh) * | 2015-11-27 | 2017-01-11 | 深圳奥萨制药有限公司 | 含依那普利和叶酸的片剂组合物及其制备方法 |
CN106963938A (zh) * | 2016-09-30 | 2017-07-21 | 南京优科制药有限公司 | 一种马来酸依那普利叶酸的药物组合物及其制备方法 |
CN107007838A (zh) * | 2016-09-30 | 2017-08-04 | 南京优科制药有限公司 | 一种含有马来酸依那普利、叶酸和酸稳定剂的药物组合物 |
CN106963938B (zh) * | 2016-09-30 | 2021-04-30 | 南京优科制药有限公司 | 一种马来酸依那普利叶酸的药物组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1269529C (zh) | 2006-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1230162C (zh) | 改进释放胰岛素致敏剂和另一抗糖尿病药的药用组合物 | |
CN1212838C (zh) | 含唑吡坦或其盐的控释剂型 | |
CN1155382C (zh) | 阿夫唑嗪盐酸盐受控释放的片剂 | |
CN1202815C (zh) | 含有曲马朵糖精盐的持续释放给药剂型 | |
CN1824320A (zh) | 含有钙通道阻滞剂和b族维生素的药物组合物及其用途 | |
CN1215338A (zh) | 包含具有血管紧张素ⅱ拮抗活性的化合物的药物组合物 | |
CN1617717A (zh) | 氨氯地平和阿托伐他汀的药物组合物 | |
CN1642530A (zh) | 基于微囊的改变释放的片剂 | |
CN1284868A (zh) | 口服药用脉冲释放剂型 | |
CN1414852A (zh) | 新组合物及其用途 | |
CN1518461A (zh) | 药物组合物 | |
CN1633282A (zh) | 可分散在口中的泡腾片剂 | |
CN1335767A (zh) | 用于高溶解度药物的缓释基质 | |
CN1638805A (zh) | 含有水溶性纤维素衍生物的iressa药物制剂 | |
CN1635885A (zh) | 应用取代吲哚化合物增强一氧化氮合酶活性 | |
CN101068550A (zh) | 含有释放速度控制组分的羧酰胺人类免疫缺陷整合酶抑制剂药物制剂 | |
CN1062289A (zh) | 治疗心、血管肥大及增生的方法 | |
CN1587270A (zh) | 含有血管紧张素转化酶抑制剂和b族维生素的药物组合物 | |
CN1765362A (zh) | 包含氨氯地平和血管紧张素ⅱ受体抑制剂的组合物 | |
CN1684669A (zh) | 包含HMG-CoA还原酶抑制剂的组合物 | |
CN1159004C (zh) | 具有高含量n-乙酰半胱氨酸的可吞咽片剂 | |
CN1587269A (zh) | 含有血管紧张素ⅱ受体拮抗剂和b族维生素的药物组合物 | |
CN1204895C (zh) | 依托泊甙肠溶缓(控)释固体分散制剂及其制备方法 | |
CN1942193A (zh) | 用于紧急糖皮质激素治疗的药物组合物 | |
CN1501798A (zh) | 包含双氯酚酸及奥诺前列素的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN OSA MEDICINE CO., LTD. Free format text: FORMER OWNER: ANHUI BIOLOGICAL MEDICAL INST. Effective date: 20080822 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080822 Address after: Shenzhen Nanshan District hi tech Zone, a high-tech incubator in Central District 1-301 Patentee after: AUSA Pharmed Ltd. Address before: 153#, Medical University Of Anhui, 81 Mei Shan Road, Anhui, Hefei Patentee before: Anhui Biological Medical Science Inst. |
|
ASS | Succession or assignment of patent right |
Owner name: SHENZHEN AUSA PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: SHENZHEN AOSA MEDICINE CO., LTD.;ANHUI BIOLOGICAL MEDICAL INSTITUTE Effective date: 20110330 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 518000 1-301, BIOLOGICAL INCUBATOR, GAOXIN MIDDLE ROAD 1, MIDDLE AREA OF HIGH-TECH. ZONE, NANSHAN DISTRICT, SHENZHEN CITY TO: 518057 1/F (EAST SIDE) AND 2-3/F OF BUILDING 3, 1-2/F OF BUILDING 2, 3RD PHASE OF BIOLOGICAL INCUBATOR, NO. 16, GAOXIN MIDDLE ROAD 1, NANSHAN HIGH-TECH. ZONE, SHENZHEN CITY, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110330 Address after: 518057, Shenzhen Nanshan hi tech Zone, Guangdong hi tech incubator, No. 16, No. three, No. 2, building first, second, building 3, 1, East and 2, 3 Patentee after: Shenzhen Aosa Pharmaceutical Co., Ltd. Address before: 518000 a biological incubator in central high tech Zone, Shenzhen, Nanshan District 1-301 Patentee before: AUSA Pharmed Ltd. |
|
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Chen Guangliang Inventor after: Wang Linlin Inventor after: Li Li Inventor after: Duan Yanyan Inventor after: Xu Xiping Inventor after: Xu Xin Inventor before: Chen Guangliang Inventor before: Wang Linlin Inventor before: Li Li Inventor before: Duan Yanyan Inventor before: Xu Xiping |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CHEN GUANGLIANG WANG LINLIN LI LI DUAN YANYAN XU XIPING TO: CHEN GUANGLIANG WANG LINLIN LI LI DUAN YANYAN XU XIPING XU XIN |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Medicinal composition contaniing angiotensin invertase inhibitor and vitamin B Effective date of registration: 20121029 Granted publication date: 20060816 Pledgee: Shenzhen SME credit financing guarantee Group Co., Ltd. Pledgor: AUSA Pharmed Ltd. Registration number: 2012990000647 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20151210 Granted publication date: 20060816 Pledgee: Shenzhen SME credit financing guarantee Group Co., Ltd. Pledgor: AUSA Pharmed Ltd. Registration number: 2012990000647 |
|
PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model |